Condition

Stage IIIA Breast Cancer

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 148 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials148

Recruiting0

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03NCT04109391 · 2019-08-20

Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast CancerNCT03091842 · 2019-07-29

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast CancerNCT03971409 · 2019-07-08

ACTIVE_NOT_RECRUITING

Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast CancerNCT03566485 · 2018-07-10

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast CancerNCT03556358 · 2018-06-28

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerNCT03414970 · 2018-03-12

ACTIVE_NOT_RECRUITING

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersNCT03112668 · 2017-12-06

4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast CancerNCT03364348 · 2017-10-30

Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast CancerNCT03102866 · 2017-08-30

Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer SurvivorsNCT03284346 · 2017-08-17

Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast CancerNCT03128619 · 2017-08-02

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast CancerNCT02860000 · 2017-07-06

Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by SurgeryNCT03044730 · 2017-05-25

Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast CancerNCT03139435 · 2017-05-11

Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast SurgeryNCT03188393 · 2017-04-13

Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)NCT03025139 · 2017-02-20

Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by SurgeryNCT02760030 · 2017-02-16

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast CaNCT02957968 · 2017-01-24

ACTIVE_NOT_RECRUITING

Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsNCT02897375 · 2016-10-24

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)NCT02728596 · 2016-10-07

Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in RemissionNCT02780401 · 2016-09-02

MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy TreatmentNCT02702830 · 2016-08-25

Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast CancerNCT03050463 · 2016-08-01

Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast CancerNCT02827877 · 2016-07-15

ACTIVE_NOT_RECRUITING

Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in WisconsinNCT02677389 · 2016-07-01

Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer SurvivorsNCT02662335 · 2016-05-01

Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast CancerNCT02432950 · 2016-03-22

eHealth Weight Loss Program in African American Breast Cancer SurvivorsNCT02699983 · 2016-01-08

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsNCT02646319 · 2016-01-01

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant ChemotherapyNCT02445391 · 2015-10-20

ACTIVE_NOT_RECRUITING

Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical ActivityNCT02566408 · 2015-10-14

High-Intensity Interval Training for Stage I-III Breast Cancer PatientsNCT02454777 · 2015-09-29

Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic MastectomyNCT03061175 · 2015-09-24

Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer SurvivorsNCT03198286 · 2015-08-01

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerNCT02488967 · 2015-07-26

ACTIVE_NOT_RECRUITING

18F-FSPG PET/CT for Cancer Patients on TherapyNCT02599194 · 2015-07-01

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast CancerNCT02203552 · 2015-06-23

Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast CancerNCT02157051 · 2015-06-01

ACTIVE_NOT_RECRUITING

Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer SurvivorsNCT03039140 · 2015-05-14

Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast CancerNCT02400060 · 2015-03-26

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast CancerNCT02315196 · 2015-02-25

ACTIVE_NOT_RECRUITING

Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast CancerNCT02370277 · 2014-12-16

KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast CancerNCT02168179 · 2014-12-01

Phase II Study of Everolimus Beyond ProgressionNCT02269670 · 2014-11-25

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerNCT02273752 · 2014-11-01

Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer SurvivorsNCT02235051 · 2014-09-07

BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxNCT02038010 · 2014-05-21

Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation TherapyNCT02023008 · 2014-05-01

Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerNCT02060253 · 2014-04-01

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryNCT01953588 · 2014-02-27

ACTIVE_NOT_RECRUITING

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyNCT01901094 · 2014-02-24

ACTIVE_NOT_RECRUITING

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyNCT02002533 · 2014-02-03

Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast CancerNCT02415387 · 2014-01-01

Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing ChemotherapyNCT01941784 · 2013-11-25

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast CancerNCT01712815 · 2013-11-22

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast CancerNCT01869764 · 2013-11-01

Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast CancerNCT01959490 · 2013-09-24

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerNCT01730833 · 2013-07-17

Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast CancerNCT01868503 · 2013-07-01

A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)NCT01824836 · 2013-06-11

ACTIVE_NOT_RECRUITING

Common interventions

Leading sponsors

National Cancer Institute (NCI) 23 University of Washington 14 University of Southern California 13 City of Hope Medical Center 9 Wake Forest University Health Sciences 9 Ohio State University Comprehensive Cancer Center 8 Rutgers, The State University of New Jersey 5 Mayo Clinic 4 Northwestern University 4 Alliance for Clinical Trials in Oncology 3 Case Comprehensive Cancer Center 3 Emory University 3 Fred Hutchinson Cancer Center 3 Roswell Park Cancer Institute 3 Stanford University 3

Trial status mix

COMPLETED90

TERMINATED36

ACTIVE_NOT_RECRUITING12

WITHDRAWN7

UNKNOWN3

Phase mix

PHASE254

NA50

PHASE133

PHASE310

EARLY_PHASE14

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.